Michel Darnaud

Chief Executive Officer chez STENTYS

Profil

Michel Paul Darnaud currently works at Stentys SA, as Chairman & Chief Executive Officer from 2019, Aditlys Medical AG, as Director, Physidia SAS, as Director, and MicroPort Cardiac Rhythm Management International Ltd., as Independent Non-Executive Director.
Mr. Darnaud also formerly worked at European Medical Device Industry Association, as Chairman from 2004 to 2005, OnSource Corp., as Director in 2005, Ceragenix Pharmaceuticals, Inc., as Director from 2005 to 2010, Xeltis AG, as Director in 2015, CorWave SA, as Independent Director, Baxter International, Inc., as President-European Cardiovascular Business, Boston Scientific Corp., as President-European Division in 2005, Diagnostica Stago, Inc., as General Manager in 1991, and LivaNova Plc, as President-Cardiac Surgery from 2015 to 2017.
Mr. Darnaud received his undergraduate degree in 1973 from École des Hautes Études Commerciales de Paris.

Postes actifs de Michel Darnaud

Sociétés	Poste	Début
STENTYS	Chief Executive Officer	10/05/2019
Physidia SAS	Director/Board Member	-
Aditlys Medical AG	Director/Board Member	-
MicroPort Cardiac Rhythm Management International Ltd.	Director/Board Member	-

Anciens postes connus de Michel Darnaud

Sociétés	Poste	Fin
LIVANOVA PLC	Corporate Officer/Principal	29/03/2017
Ceragenix Pharmaceuticals, Inc.	Director/Board Member	23/07/2010
OnSource Corp.	Director/Board Member	27/06/2005
BOSTON SCIENTIFIC CORPORATION	Corporate Officer/Principal	01/06/2005
European Medical Device Industry Association	Chairman	01/01/2005

Formation de Michel Darnaud

École des Hautes Études Commerciales de Paris

Undergraduate Degree